The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.Patients taking semag ...

Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...

This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...

Lizzo is getting in on the joke with a new Halloween costume that spoofs a bit from 'South Park: The End of Obesity.' ...

City employees in NYC had insurance coverage for GLP-1 drugs like Wegovy and Zepbound for less than a year before learning it ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may also help lower the risk of developing Alzheimer’s disease in ...